Study title:
Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.
Dig Liver Dis. 2004 May;36(5):342-7.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Immune System Diseases
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: Azathioprine |
ATC code: L04AX01 |
Document link:
|
Document date: 2015-03-04
|
Study number: PMID: 15191204
|
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|